MEASURING EFFICIENCY OF PHARMACEUTICAL COMPANIES OF THE REPUBLIC OF UZBEKISTAN
;
technical efficiency, Data envelopment analysis, slacks, target values, Uzbek pharmaceutical companies.Abstrak
This paper presents a Data Envelopment analysis (DEA) for measuring efficiency of pharmaceutical companies. Letting each of fifteen companies in each year be a separate decision-making unit, and utilizing three inputs and one output, we measure annual efficiency values, slacks and target units of Uzbek local pharmaceutical companies for decade 2010-2019 as defined by the period of variables. Measuring efficiencies for every year together with slack values and suggested target monetary values, we empirically show that on average 5 firms (Reka med, Dentafil, Torimed pharm, SEEM and Uzgermed) out of 15 were inefficient every year. However, inefficiency was not significant, varying around 0.80-0.99. Throughout the study decade, most frequent slacks were depicted in excess input utilization rather than output usage.
Iqtiboslar
Abdurakhmonov, J. U. Research of the pharmaceutical market of Uzbekistan and prospects of its development / J. U. Abdurakhmonov O. M. Voronina // Topical issues of new drugs development : abstracts оf XXIV international scientific and practical conference of young scientists and student, April 20, 2017. - Kh., 2017. - Vol. 2. - P. 193-194.
VAYTON (2019). Pharmaceutical market of Uzbekistan. [online] Slideshare.net. Available at: https://www.slideshare.net/vaytonbrandcapital/pharmaceutical-market-of-uzbekistan [Accessed 14 Oct. 2019].
Akihiro Hashimoto, Shoko Haneda Measuring the change in R&D efficiency of the Japanese
pharmaceutical industry / Research Policy 37 (2008) 1829–1836
Honjo, Y., Haneda, S.: R&D evaluation of Japanese pharmaceutical firms using DEA. J. Sci. Policy Res. Manag. 13, 96–105 (1998))).
Taewoo Youa,*, Xiaoying Chenb and Mark E. Holder Efficiency and its determinants in pharmaceutical industries: ownership, R&D and scale economy Applied Economics, 2010, 42, 2217–2241
Mao, Y., Li, J., Liu, Y.: Evaluating business performance of China’s pharmaceutical companies based on data envelopment analysis. Stud. Ethno Med. 8, 51–60 (2014)
